KR20220161436A - 올리고뉴클레오티드 및 관련 화합물의 합성 - Google Patents

올리고뉴클레오티드 및 관련 화합물의 합성 Download PDF

Info

Publication number
KR20220161436A
KR20220161436A KR1020227037806A KR20227037806A KR20220161436A KR 20220161436 A KR20220161436 A KR 20220161436A KR 1020227037806 A KR1020227037806 A KR 1020227037806A KR 20227037806 A KR20227037806 A KR 20227037806A KR 20220161436 A KR20220161436 A KR 20220161436A
Authority
KR
South Korea
Prior art keywords
formula
compound
group
moiety
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227037806A
Other languages
English (en)
Korean (ko)
Inventor
민홍 중
이 진
디네시 갈라
마리자 프라브
Original Assignee
얀센 바이오파마, 인코퍼레이트.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 얀센 바이오파마, 인코퍼레이트. filed Critical 얀센 바이오파마, 인코퍼레이트.
Publication of KR20220161436A publication Critical patent/KR20220161436A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
KR1020227037806A 2020-03-31 2021-03-30 올리고뉴클레오티드 및 관련 화합물의 합성 Pending KR20220161436A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063003067P 2020-03-31 2020-03-31
US63/003,067 2020-03-31
PCT/IB2021/052595 WO2021198883A1 (en) 2020-03-31 2021-03-30 Synthesis of oligonucleotides and related compounds

Publications (1)

Publication Number Publication Date
KR20220161436A true KR20220161436A (ko) 2022-12-06

Family

ID=75340013

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227037806A Pending KR20220161436A (ko) 2020-03-31 2021-03-30 올리고뉴클레오티드 및 관련 화합물의 합성

Country Status (11)

Country Link
US (1) US12649761B2 (enExample)
EP (1) EP4126894A1 (enExample)
JP (1) JP2023520201A (enExample)
KR (1) KR20220161436A (enExample)
CN (1) CN115843299A (enExample)
AU (1) AU2021247043A1 (enExample)
BR (1) BR112022019752A2 (enExample)
CA (1) CA3178892A1 (enExample)
IL (1) IL296862A (enExample)
MX (1) MX2022012255A (enExample)
WO (1) WO2021198883A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12649761B2 (en) 2020-03-31 2026-06-09 Janssen Biopharma, Inc. Synthesis of oligonucleotides and related compounds
CN116888136A (zh) 2021-02-12 2023-10-13 味之素株式会社 寡核苷酸的制备方法
EP4601656A1 (en) * 2022-10-12 2025-08-20 Pharmorage Pty Limited Modified oligonucleotides
EP4755898A1 (en) 2023-08-02 2026-06-10 Nitto Denko Corporation Method for producing oligonucleotide
WO2025235761A1 (en) * 2024-05-09 2025-11-13 Biogen Ma Inc. Reagents and processes for preparing oligonucleotides

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001704A1 (en) 1990-07-26 1992-02-06 Koichi Shudo Oligodeoxyribonucleotides
US6972330B2 (en) * 1996-02-13 2005-12-06 Sirna Therapeutics, Inc. Chemical synthesis of methoxy nucleosides
US5753789A (en) 1996-07-26 1998-05-19 Yale University Oligonucleotides containing L-nucleosides
ES2192672T3 (es) 1996-11-18 2003-10-16 Takeshi Imanishi Nuevos analogos de nucleotidos.
US6770748B2 (en) 1997-03-07 2004-08-03 Takeshi Imanishi Bicyclonucleoside and oligonucleotide analogue
JP3756313B2 (ja) 1997-03-07 2006-03-15 武 今西 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
US6251666B1 (en) 1997-03-31 2001-06-26 Ribozyme Pharmaceuticals, Inc. Nucleic acid catalysts comprising L-nucleotide analogs
US6794499B2 (en) 1997-09-12 2004-09-21 Exiqon A/S Oligonucleotide analogues
EP1015469B2 (en) 1997-09-12 2015-11-18 Exiqon A/S Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
BRPI0008131B8 (pt) 1999-02-12 2021-05-25 Daiichi Sankyo Co Ltd composto ou um sal deste, análogo de oligonucleotídeo, composição farmacêutica, sonda para um gene,iniciador para começar a amplificação, uso de um análogo de oligonucleotídeo ou de um sal deste farmacologicamente aceitável, agente antisentido, e, agente antígeno
JP2000247940A (ja) * 1999-02-26 2000-09-12 Sankyo Co Ltd 新規ベンジルアジド化合物
US7084125B2 (en) 1999-03-18 2006-08-01 Exiqon A/S Xylo-LNA analogues
ATE356824T1 (de) 1999-05-04 2007-04-15 Santaris Pharma As L-ribo-lna analoge
US6525191B1 (en) 1999-05-11 2003-02-25 Kanda S. Ramasamy Conformationally constrained L-nucleosides
JP4151751B2 (ja) 1999-07-22 2008-09-17 第一三共株式会社 新規ビシクロヌクレオシド類縁体
US7569575B2 (en) 2002-05-08 2009-08-04 Santaris Pharma A/S Synthesis of locked nucleic acid derivatives
CA2504694C (en) 2002-11-05 2013-10-01 Isis Pharmaceuticals, Inc. Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
CN101684136A (zh) * 2008-09-23 2010-03-31 苏州瑞博生物技术有限公司 一种寡核苷酸的制备方法
WO2013179412A1 (ja) 2012-05-30 2013-12-05 北海道システム・サイエンス株式会社 高分散性液相支持体を用いたオリゴヌクレオチド合成法
US10214555B2 (en) 2012-11-14 2019-02-26 Takeda Pharmaceutical Company Limitjed Method for liquid-phase synthesis of nucleic acid
EP3398955B1 (en) 2015-12-16 2026-06-03 Ajinomoto Co., Inc. Oligonucleotide production method, and nucleoside, nucleotide, or oligonucleotide
JPWO2017111137A1 (ja) 2015-12-22 2018-10-18 味の素株式会社 オリゴヌクレオチドの製造方法
JP7306263B2 (ja) 2017-05-02 2023-07-11 日産化学株式会社 オリゴヌクレオチドの製造方法
US12649761B2 (en) 2020-03-31 2026-06-09 Janssen Biopharma, Inc. Synthesis of oligonucleotides and related compounds

Also Published As

Publication number Publication date
AU2021247043A1 (en) 2022-10-27
US12649761B2 (en) 2026-06-09
MX2022012255A (es) 2023-01-11
CN115843299A (zh) 2023-03-24
EP4126894A1 (en) 2023-02-08
IL296862A (en) 2022-11-01
CA3178892A1 (en) 2021-10-07
BR112022019752A2 (pt) 2022-11-16
JP2023520201A (ja) 2023-05-16
US20240092821A1 (en) 2024-03-21
WO2021198883A1 (en) 2021-10-07

Similar Documents

Publication Publication Date Title
JP2023520201A (ja) オリゴヌクレオチド及び関連化合物の合成
US12590115B2 (en) Technologies useful for oligonucleotide preparation
ES2439591T3 (es) Análogos de ácido nucleico de tetrahidropirano
Langkjær et al. UNA (unlocked nucleic acid): a flexible RNA mimic that allows engineering of nucleic acid duplex stability
RU2572826C2 (ru) Способ синтеза модифицированных по атому фосфора нуклеиновых кислот
CN103068834B (zh) 用于反向合成rna的亚磷酰胺
Lönnberg Synthesis of oligonucleotides on a soluble support
CN111108096A (zh) 寡核苷酸制备技术
KR20210005057A (ko) 올리고뉴클레오티드 조성물 및 이의 이용 방법
CN102180924A (zh) L-核糖-lna类似物
KR102190852B1 (ko) 변형된 커플링 프로토콜을 이용하는 올리고머 화합물의 제조 방법
KR20190065341A (ko) 올리고머 화합물들의 접합 방법
JP7640461B2 (ja) 核酸オリゴマーの製造方法
EP0818460B1 (de) Festphasensynthese von Oligonucleotiden
US20190031702A1 (en) Compounds and Methods for the Synthesis of 5-(N-Protected-Tryptaminocarboxyamide)-2'-Deoxyuridine Phosphoramidate for Incorporation into a Nucleic Sequence
JP7719788B2 (ja) 核酸オリゴマーの製造方法
Romainczyk et al. Attachment of nitroxide spin labels to nucleic acids for EPR
BR112021018492B1 (pt) Método para preparar um oligonucleotídeo e oligonucleotídeo
WO2004048376A1 (ja) 二環性ナフチリジンヌクレオシド
WO2025021654A1 (en) Phosphoramidite linkers
Hartsel et al. Solid-phase synthesis of carbohydrate and phosphodiester modified 2′–5′ oligoadenylate analogs
HK40019008A (en) Technologies for oligonucleotide preparation
Grajkowski et al. Biotinylation of a Propargylated Cyclic (3′‐5′) Diguanylic Acid and of Its Mono‐6‐Thioated Analog Under “Click” Conditions

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902